A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising concerns about potential...

A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the risk of dementia in...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent pharmaceutical advances...

The promise of help with weight loss is always alluring. But what if that solution comes with a few hidden risks?In South Africa, where obesity rates...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest influences prescription...

Anytime a person turns the TV on, they may see an ad for Ozempic or Mounjaro. These drugs have made headlines lately because they help men and women...

FRIDAY, Feb. 7, 2025 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the field of...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor agonists.